Switch to: References

Add citations

You must login to add citations.
  1. Letter to the Editor.Ray Greek - 2014 - Theoretical Medicine and Bioethics 35 (5):389-394.
    Dear Editor,The April 2014 issue of Theoretical Medicine and Bioethics [1] presented eight essays regarding the use of nonhuman animals in biomedical research. While I appreciate the essays concerning contemporary research—which were well written and offered new thinking from the fields of ethics and ethology—I believe the journal, via the topics and the authors chosen, failed to communicate the most important fact regarding the current science pertinent to the use of nonhuman animals in research.The foundational reason for using chimpanzees and (...)
    Direct download (2 more)  
     
    Export citation  
     
    Bookmark  
  • Should Biomedical Research with Great Apes Be Restricted? A Systematic Review of Reasons.David DeGrazia, Javiera Perez Gomez & Bernardo Aguilera - 2021 - BMC Medical Ethics 22 (1):1-20.
    BackgroundThe use of great apes in invasive biomedical research is one of the most debated topics in animal ethics. GA are, thus far, the only animal group that has frequently been banned from invasive research; yet some believe that these bans could inaugurate a broader trend towards greater restrictions on the use of primates and other animals in research. Despite ongoing academic and policy debate on this issue, there is no comprehensive overview of the reasons advanced for or against restricting (...)
    No categories
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Vaccines, Apes, and Conspiracy.Emilio Mordini - 2018 - American Journal of Bioethics 18 (10):55-57.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark  
  • Human Stakeholders and the Use of Animals in Drug Development.Lisa A. Kramer & Ray Greek - 2018 - Business and Society Review 123 (1):3-58.
    Pharmaceutical firms seek to fulfill their responsibilities to stakeholders by developing drugs that treat diseases. We evaluate the social and financial costs of developing new drugs relative to the realized benefits and find the industry falls short of its potential. This is primarily due to legislation-mandated reliance on animal test results in early stages of the drug development process, leading to a mere 10 percent success rate for new drugs entering human clinical trials. We cite hundreds of biomedical studies from (...)
    No categories
    Direct download (7 more)  
     
    Export citation  
     
    Bookmark  
  • An Experimental Ethics, but an Ethical Experiment? Anthropological Perspectives on Using Unproven Vaccines on Endangered Primates.Courtney Addison & Nicholas Malone - 2018 - American Journal of Bioethics 18 (10):53-55.
    Direct download (3 more)  
     
    Export citation  
     
    Bookmark   1 citation